Correlation Between Karuna Therapeutics and Cerevel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Karuna Therapeutics and Cerevel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karuna Therapeutics and Cerevel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karuna Therapeutics and Cerevel Therapeutics Holdings, you can compare the effects of market volatilities on Karuna Therapeutics and Cerevel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karuna Therapeutics with a short position of Cerevel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karuna Therapeutics and Cerevel Therapeutics.
Diversification Opportunities for Karuna Therapeutics and Cerevel Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Karuna and Cerevel is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Karuna Therapeutics and Cerevel Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerevel Therapeutics and Karuna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karuna Therapeutics are associated (or correlated) with Cerevel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerevel Therapeutics has no effect on the direction of Karuna Therapeutics i.e., Karuna Therapeutics and Cerevel Therapeutics go up and down completely randomly.
Pair Corralation between Karuna Therapeutics and Cerevel Therapeutics
Given the investment horizon of 90 days Karuna Therapeutics is expected to generate 0.41 times more return on investment than Cerevel Therapeutics. However, Karuna Therapeutics is 2.45 times less risky than Cerevel Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Cerevel Therapeutics Holdings is currently generating about -0.01 per unit of risk. If you would invest 21,048 in Karuna Therapeutics on September 1, 2024 and sell it today you would lose (737.00) from holding Karuna Therapeutics or give up 3.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 37.38% |
| Values | Daily Returns |
Karuna Therapeutics vs. Cerevel Therapeutics Holdings
Performance |
| Timeline |
| Karuna Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cerevel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Karuna Therapeutics and Cerevel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karuna Therapeutics and Cerevel Therapeutics
The main advantage of trading using opposite Karuna Therapeutics and Cerevel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karuna Therapeutics position performs unexpectedly, Cerevel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will offset losses from the drop in Cerevel Therapeutics' long position.| Karuna Therapeutics vs. Blueprint Medicines Corp | Karuna Therapeutics vs. Amylyx Pharmaceuticals | Karuna Therapeutics vs. Day One Biopharmaceuticals | Karuna Therapeutics vs. X4 Pharmaceuticals |
| Cerevel Therapeutics vs. Avidity Biosciences | Cerevel Therapeutics vs. Revolution Medicines | Cerevel Therapeutics vs. Day One Biopharmaceuticals | Cerevel Therapeutics vs. SpringWorks Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |